Gene therapy strategies in neurodegenerative diseases.
Identifieur interne : 003580 ( Main/Exploration ); précédent : 003579; suivant : 003581Gene therapy strategies in neurodegenerative diseases.
Auteurs : M. Giménez Y Ribotta [France]Source :
- Histology and histopathology [ 0213-3911 ] ; 2001.
English descriptors
- KwdEn :
- Alzheimer Disease (therapy), Amyotrophic Lateral Sclerosis (therapy), Animals, Deafness (therapy), Genetic Therapy (methods), Genetic Vectors, Humans, Huntington Disease (therapy), Neurodegenerative Diseases (therapy), Neurons, Parkinson Disease (therapy), Parkinsonian Disorders (therapy), Promoter Regions, Genetic, Retinitis Pigmentosa (therapy).
- MESH :
Abstract
Treatment of neurodegenerative diseases by classical pharmacotherapy is restricted by blood-brain barrier which prevents access to the brain of potentially therapeutic molecules. Recent progress in the knowledge of pathophysiological molecular processes, and in the development of molecular biotechnology have opened the way to new therapeutic interventions for these disorders. This chapter reviews the most recent gene therapy strategies using experimental models for neurodegenerative diseases.
PubMed: 11510980
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001238
- to stream PubMed, to step Curation: 001197
- to stream PubMed, to step Checkpoint: 001197
- to stream Ncbi, to step Merge: 000204
- to stream Ncbi, to step Curation: 000204
- to stream Ncbi, to step Checkpoint: 000204
- to stream Main, to step Merge: 003B44
- to stream Main, to step Curation: 003580
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gene therapy strategies in neurodegenerative diseases.</title><author><name sortKey="Gimenez Y Ribotta, M" sort="Gimenez Y Ribotta, M" uniqKey="Gimenez Y Ribotta M" first="M" last="Giménez Y Ribotta">M. Giménez Y Ribotta</name><affiliation wicri:level="1"><nlm:affiliation>INSERM U.336, Development, Plasticity and Aging of the Nervous System, University of Montpellier II, France. mgyr@univ-montp2.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM U.336, Development, Plasticity and Aging of the Nervous System, University of Montpellier II</wicri:regionArea><wicri:noRegion>University of Montpellier II</wicri:noRegion><wicri:noRegion>University of Montpellier II</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2001">2001</date><idno type="RBID">pubmed:11510980</idno><idno type="pmid">11510980</idno><idno type="wicri:Area/PubMed/Corpus">001238</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001238</idno><idno type="wicri:Area/PubMed/Curation">001197</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001197</idno><idno type="wicri:Area/PubMed/Checkpoint">001197</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001197</idno><idno type="wicri:Area/Ncbi/Merge">000204</idno><idno type="wicri:Area/Ncbi/Curation">000204</idno><idno type="wicri:Area/Ncbi/Checkpoint">000204</idno><idno type="wicri:doubleKey">0213-3911:2001:Gimenez Y Ribotta M:gene:therapy:strategies</idno><idno type="wicri:Area/Main/Merge">003B44</idno><idno type="wicri:Area/Main/Curation">003580</idno><idno type="wicri:Area/Main/Exploration">003580</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Gene therapy strategies in neurodegenerative diseases.</title><author><name sortKey="Gimenez Y Ribotta, M" sort="Gimenez Y Ribotta, M" uniqKey="Gimenez Y Ribotta M" first="M" last="Giménez Y Ribotta">M. Giménez Y Ribotta</name><affiliation wicri:level="1"><nlm:affiliation>INSERM U.336, Development, Plasticity and Aging of the Nervous System, University of Montpellier II, France. mgyr@univ-montp2.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM U.336, Development, Plasticity and Aging of the Nervous System, University of Montpellier II</wicri:regionArea><wicri:noRegion>University of Montpellier II</wicri:noRegion><wicri:noRegion>University of Montpellier II</wicri:noRegion></affiliation></author></analytic><series><title level="j">Histology and histopathology</title><idno type="ISSN">0213-3911</idno><imprint><date when="2001" type="published">2001</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alzheimer Disease (therapy)</term><term>Amyotrophic Lateral Sclerosis (therapy)</term><term>Animals</term><term>Deafness (therapy)</term><term>Genetic Therapy (methods)</term><term>Genetic Vectors</term><term>Humans</term><term>Huntington Disease (therapy)</term><term>Neurodegenerative Diseases (therapy)</term><term>Neurons</term><term>Parkinson Disease (therapy)</term><term>Parkinsonian Disorders (therapy)</term><term>Promoter Regions, Genetic</term><term>Retinitis Pigmentosa (therapy)</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Genetic Therapy</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Alzheimer Disease</term><term>Amyotrophic Lateral Sclerosis</term><term>Deafness</term><term>Huntington Disease</term><term>Neurodegenerative Diseases</term><term>Parkinson Disease</term><term>Parkinsonian Disorders</term><term>Retinitis Pigmentosa</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Genetic Vectors</term><term>Humans</term><term>Neurons</term><term>Promoter Regions, Genetic</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Treatment of neurodegenerative diseases by classical pharmacotherapy is restricted by blood-brain barrier which prevents access to the brain of potentially therapeutic molecules. Recent progress in the knowledge of pathophysiological molecular processes, and in the development of molecular biotechnology have opened the way to new therapeutic interventions for these disorders. This chapter reviews the most recent gene therapy strategies using experimental models for neurodegenerative diseases.</div></front></TEI><affiliations><list><country><li>France</li></country></list><tree><country name="France"><noRegion><name sortKey="Gimenez Y Ribotta, M" sort="Gimenez Y Ribotta, M" uniqKey="Gimenez Y Ribotta M" first="M" last="Giménez Y Ribotta">M. Giménez Y Ribotta</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003580 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003580 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:11510980
|texte= Gene therapy strategies in neurodegenerative diseases.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:11510980" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |